1. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2. |
de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med, 2020, 382(6): 503-513.
|
3. |
Archer JM, Mendoza DP, Hung YP, et al. Surgical resection of benign nodules in lung cancer screening: Incidence and features. JTO Clin Res Rep, 2023, 4(12): 100605.
|
4. |
Mazzone PJ, Silvestri GA, Souter LH, et al. Executive summary: Screening for lung cancer: Chest guideline and expert panel report. Chest, 2021, 160(5): 1959-1980.
|
5. |
Mazzone PJ, Silvestri GA, Souter LH, et al. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest, 2021, 160(5): e427-e494.
|
6. |
郭芳芳, 李欣菱, 王欣悦, 等. 亚实性肺结节CT征象在良恶性鉴别及腺癌恶性侵袭程度评估中的价值. 中国肺癌杂志, 2018, 21(6): 451-457.
|
7. |
Tammemägi MC, Church TR, Hocking WG, et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: Screening rules applied to the PLCO and NLST cohorts. PLoS Med, 2014, 11(12): e1001764.
|
8. |
Horeweg N, van der Aalst CM, Vliegenthart R, et al. Volumetric computed tomography screening for lung cancer: Three rounds of the NELSON trial. Eur Respir J, 2013, 42(6): 1659-1667.
|
9. |
Patz EF, Pinsky P, Gatsonis C, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med, 2014, 174(2): 269-274.
|
10. |
Jiang Y, Deng T, Huang Y, et al. Developing a multi-institutional nomogram for assessing lung cancer risk in patients with 5-30 mm pulmonary nodules: a retrospective analysis. PeerJ, 2023, 11: e16539.
|
11. |
Mazzone PJ, Lam L. Evaluating the patient with a pulmonary nodule: A review. JAMA, 2022, 327(3): 264-273.
|
12. |
石峰, 王昕, 王全用, 等. 低剂量螺旋CT在肺部结节筛查中的应用价值研究. 影像研究与医学应用, 2021, 5(23): 84-85.
|
13. |
张承刚. 毛刺征在CT诊断周围型小肺癌中的价值. 影像研究与医学应用, 2020, 4(12): 124-125.
|
14. |
Meisinger QC, Klein JS, Butnor KJ, et al. CT features of peripheral pulmonary carcinoid tumors. AJR Am J Roentgenol, 2011, 197(5): 1073-1080.
|
15. |
周程敏, 严肃, 单海荣, 等. 肺磨玻璃结节CT影像学特征分析. 中国医学装备, 2022, 19(9): 19-22.
|
16. |
章智荣, 毛友生. 孤立性肺结节病变的诊断与处理策略. 中国肺癌杂志, 2013(9): 499-508.
|
17. |
Truong MT, Ko JP, Rossi SE, et al. Update in the evaluation of the solitary pulmonary nodule. Radiographics, 2014, 34(6): 1658-1679.
|
18. |
张东军, 刘丽伟, 刘洋, 等. 胸膜凹陷征在胸膜下磨玻璃结节诊断中的价值. 东南大学学报(医学版), 2020, 39(3): 297-300.
|
19. |
Hu H, Wang Q, Tang H, et al. Multi-slice computed tomography characteristics of solitary pulmonary ground-glass nodules: Differences between malignant and benign. Thorac Cancer, 2016, 7(1): 80-87.
|
20. |
Shi CZ, Zhao Q, Luo LP, et al. Size of solitary pulmonary nodule was the risk factor of malignancy. J Thorac Dis, 2014, 6(6): 668-676.
|
21. |
肖寿勇, 吴四云, 赵炜杰, 等. 浸润性肺腺癌高分辨率CT征象与病理亚型的对照研究. 临床放射学杂志, 2022, 41(1): 75-80.
|
22. |
Duan X, Ouyang Z, Bao S, et al. Factors associated with overdiagnosis of benign pulmonary nodules as malignancy: A retrospective cohort study. BMC Pulm Med, 2023, 23(1): 454.
|
23. |
Hsu L, Achkar JM, Keller SM, et al. National trends in benign pulmonary resections: Association with CT and PET imaging. Chest, 2015, 147(2): e61-e62.
|